Johnson & Johnson

Nvidia Teams Up With Johnson & Johnson to Develop New AI Tools for Surgery

Nvidia Teams Up With Johnson & Johnson to Develop New AI Tools for Surgery

Nvidia has partnered with Johnson & Johnson to develop new AI applications to help doctors perform surgery.

Read Full Article

Working Mothers Magazine cited excellent companies for working moms

It's no longer unusual if you see working mothers in the office, streets, or restaurants. With the high cost of living, children's education, and bills to pay, couples should help each other to make both ends meet.

Read Full Article

America Makes' $8M funding for commercialization of new technologies

With an objective of taking additive manufacturing (3-D printing) to further advance level, America Makes has drawn up plans to support research and development (R&D) with financial funding of up to $8 million.

Read Full Article

IBM launches new health unit, teams up with Apple, J&J, Medtronic

International Business Machines Corp, deepening its partnership with Apple Inc to make use of health information gathered by millions of Apple devices, is creating a unit dedicated to providing data analytics to the healthcare sector.

Read Full Article

Galapagos loses partner on inflammatory bowel drug

Belgian biotech group Galapagos said on Tuesday that its research partner Janssen Pharmaceutica, a unit of Johnson & Johnson, had pulled out of a program to develop a new drug to treat bowel disease.

Read Full Article

Medtronic wins conditional EU approval for $43 billion Covidien buy

U.S. medical device maker Medtronic (MDT.N) gained European Union regulatory approval on Friday for its $43 billion takeover of Covidien Plc (COV.N) after agreeing to sell its Irish rival's drug-coated balloon catheter business.

Read Full Article

J&J seeks over $5 billion in damages from Boston Scientific at trial

Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.

Read Full Article

Johnson & Johnson to buy private drug developer for $1.75 billion

Johnson & Johnson (JNJ.N) agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma Inc, which is developing a drug for a common respiratory viral infection in children for which there is no approved treatment.

Read Full Article

Johnson & Johnson to seek buyer for medical device maker unit

Johnson & Johnson (JNJ.N) plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.

Read Full Article

IBM launches Watson system for research, hopes for breakthroughs

International Business Machines Corp on Wednesday launched a computer system that can quickly identify patterns in massive amounts of data, an ability that IBM said should hasten breakthroughs in science and medical research.

Read Full Article

Apps put fitness fans through short, sharp workouts

Fitness buffs who can't make it to the gym but still want to exercise can turn to apps for a short, intense workout when they are pressed for time. The U.S. Centers for Disease Control recommend that adults do at least 150 minutes of moderate aerobic activity weekly. But recent studies suggest even short bouts of exercise can have positive health effects.

Read Full Article

Chicago software firm Wellspring bags $3.5M in funding

Illinois, US-based software systems provider Wellspring Worldwide bagged $3.5 million in funding from undisclosed investors, according to a document filed with the US Securities and Exchange Commission.

Read Full Article

Carlyle acquires J&J unit, joins others in making purchases in the New Year

As the New Year starts to roll, private equity firm Carlyle joins the other firms racing to make acquisitions with its $4.15 billion purchase of a Johnson&Johnson unit, the Financial Times reported.

Read Full Article

Pharmaceutical firms introduce new drugs but encounter selling difficulties- report

After lackluster activity in the past years, pharmaceutical firms have gotten back to producing new drugs but they encounter challenges in selling them, according to a report on The Wall Street Journal.

Read Full Article

Accelrys picks up Irish software firm Qumas in $50M takeover deal

California, US-based software developing company Accelrys has acquired Ireland-based software business Qumas in a deal valued at $50 million to expand its products expansion and client base.

Read Full Article
1 2

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics